Biotech Calendar: Key Dates for March
BOSTON (TheStreet) -- A calendar of important, potentially stock-moving biotech events for March:
March 2-3
RBC Capital Markets Healthcare Conference
March 4
Bristol-Myers Squibb investor/analyst meeting (BMY) March 5-7 ASCO Genitourinary Cancers Symposium: Dendreon (DNDN) presenting updated data from the phase III study of Provenge March 8-11 Cowen & Co Healthcare Conference March 9 FDA advisory panel meets to discuss InterMune's (ITMN) pirfenidone for the treatment of idiopathic pulmonary fibrosis. The FDA's briefing documents for this meeting likely available on March 5 or March 8. March 12 FDA approval decision date for exenatide once weekly for diabetes, developed by Amylin Pharmaceuticals (AMLN) and Alkermes (ALKS), co-marketed by Eli Lilly (LLY). March 14-16 American College of Cardiology annual meeting March 19 Viropharma (VPHM) investor/analyst meetingSelect the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
